Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Athena Pharmaceutiques aggregated by PharmaCompass.com.

    Client Virtual Booth

    ATHENA PHARMACEUTIQUES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    Key Products KEY PRODUCTS

    • Amphotericin B

    • Bilastine

    • Choline Fenofibrate

    • Etifoxine

    • Fenofibrate

    • Josamycin

    • Ketorolac Trometamol

    • Levocetirizine Dihydrochloride

    • Mesalazine

    • Ondansetron

    • Ondansetron Hydrochloride

    • Paracetamol

    • Prednisolone

    • Prednisolone Acetate

    • Prednisolone Hemisuccinate

    • Racecadotril

    • Secnidazole

    • Tramadol Hydrochloride

    • Tranexamic Acid

    • Trazodone Hydrochloride

    • Zolpidem Tartrate

    SERVICES

    Key Products KEY SERVICES

    • ODT Development & Manufacturing

    • Taste Masking

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Athena DDS
    Athena Pharmaceutiques
    France Flag
    Country
    Country
    France
    Address
    Address
    Bat D 6e étage Bureaux de la colline 92210 St Cloud
    Telephone
    Telephone
    +33 327434500
    Client Email
    Email
    contact@ddsathena.com
    Client Website
    Website
    https://athenapharmaceutiques.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/athena-drug-delivery-solutions-pvt-ltd/
    Twitter
    Twitter
    Contact Info
    Others

    Full View ScreenFull Screen View
    Very successful capital increase for NFL Biosciences with over €3 million raised
    Very successful capital increase for NFL Biosciences with over €3 million raised

    https://www.globenewswire.com/news-release/2023/01/31/2598055/0/en/NFL-BIOSCIENCES-Very-successful-capital-increase-for-NFL-Biosciences-with-over-3-million-raised.html

    GLOBENEWSWIRE
    31 Jan 2023
    Share Share
    NFL Biosciences: 2022 first-half business and earnings
    NFL Biosciences: 2022 first-half business and earnings

    https://www.globenewswire.com/news-release/2022/10/25/2540438/0/en/NFL-Biosciences-2022-first-half-business-and-earnings.html

    GLOBENEWSWIRE
    25 Oct 2022
    Share Share
    Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai
    Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai

    https://athenapharmaceutiques.com/wp-content/uploads/2022/11/Inaugration-of-new-RD-Facility-in-India.pdf

    PRESS RELEASE
    30 Sep 2022
    Share Share
    Athena’s First Market Authorization in Brazil with Ondansetron ODT
    Athena’s First Market Authorization in Brazil with Ondansetron ODT

    https://athenapharmaceutiques.com/wp-content/uploads/2022/03/March-2022-Athenas-First-Market-Authorization-in-Brazil-with-Ondansetron-ODT.pdf

    PRESS RELEASE
    22 Mar 2022
    Share Share
    NFL BIOSCIENCES: co-development agreement for a drug candidate
    NFL BIOSCIENCES: co-development agreement for a drug candidate

    https://www.globenewswire.com/en/news-release/2022/02/02/2377867/0/en/NFL-BIOSCIENCES-co-development-agreement-for-a-drug-candidate-to-reduce-alcohol-consumption.html

    GLOBENEWSWIRE
    02 Feb 2022
    Share Share
    Athena steps up its R&D output in France and India
    Athena steps up its R&D output in France and India

    https://athenapharmaceutiques.com/wp-content/uploads/2021/12/Athena-steps-up-its-RD-output-in-France-and-India.pdf

    PRESS RELEASE
    18 Nov 2021
    Share Share
    The call for help from generic drug manufacturers
    The call for help from generic drug manufacturers

    https://www.lefigaro.fr/societes/l-appel-a-l-aide-des-fabricants-de-medicaments-generiques-20211012

    Keren Lentschner LEFIGARO
    12 Oct 2021
    Share Share
    Athena Pharmaceutiques acquires Bisoprolol + Aspirin Capsules Dossier and Patent
    Athena Pharmaceutiques acquires Bisoprolol + Aspirin Capsules Dossier and Patent

    https://athenapharmaceutiques.com/wp-content/uploads/2021/12/Bisoprolol-Aspirin-Acquisition-Athena-Oct-2021-Final.pdf

    PRESS RELEASE
    07 Oct 2021
    Share Share
    Athena Inpharmasci approved by Korean and Taiwan GMP following
    Athena Inpharmasci approved by Korean and Taiwan GMP following

    https://athenapharmaceutiques.com/wp-content/uploads/2021/12/Final-Athena-IPS-approved-by-Korean-and-Taiwan-GMP-2021-february.pdf

    PRESS RELEASE
    10 Feb 2021
    Share Share
    ATHENA’s First Launch in Russia with Levocetirizine ODT
    ATHENA’s First Launch in Russia with Levocetirizine ODT

    https://athenapharmaceutiques.com/wp-content/uploads/2020/12/Levocetirizine-ODT-Launch-in-Russia.pdf

    PRESS RELEASE
    16 Oct 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    #SpeakPharma

    Athena DDS

    Pharma Meeting Brazil

    Attending

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search